Other OTC - Delayed Quote USD

Item 9 Labs Corp. (INLB)

0.0001 0.0000 (0.00%)
At close: May 13 at 9:30 AM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2023)Next Year (2024)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS -0.04-0.04----

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2023)Next Year (2024)
No. of Analysts 1111
Avg. Estimate 4.5M5.5M23.5M30M
Low Estimate 4.5M5.5M23.5M30M
High Estimate 4.5M5.5M23.5M30M
Year Ago Sales 6.19M6.64M21.76M23.5M
Sales Growth (year/est) -27.30%-17.10%8.00%27.70%

Earnings History

CURRENCY IN USD 12/31/2021 3/31/2022 6/30/2022 9/30/2022
EPS Est. -0.04-0.03-0.03-0.04
EPS Actual -0.04-0.04-0.06-0.2
Difference 0-0.01-0.03-0.16
Surprise % 0.00%-33.30%-100.00%-400.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2023)Next Year (2024)
Current Estimate 0000
7 Days Ago -0.05-0.04-0.13-0.08
30 Days Ago -0.05-0.04-0.13-0.08
60 Days Ago -0.05-0.04-0.13-0.08
90 Days Ago -0.05-0.04-0.13-0.08

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2023)Next Year (2024)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD INLBIndustrySectorS&P 500
Current Qtr. ------7.30%
Next Qtr. ------10.90%
Current Year ------4.60%
Next Year ------13.00%
Next 5 Years (per annum) ------10.89%
Past 5 Years (per annum) --------

Research Analysis

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Initiated Noble Capital Markets: Outperform 7/22/2021

Related Tickers